Supplying Honey to Clinical Buyers: What the Grade Actually Means
When clinical supply chain buyers source honey, they are not making a purchasing decision based on general quality claims or country of origin. They are sourcing a specific material to a specific grade, verified by a specific method, with batch-level documentation that supports their own compliance obligations downstream.
This post is written for buyers in clinical and wound care supply channels who need to understand how WA honey is graded, tested, and documented for supply at that level. It covers the grading framework, the verification method, the distinction between food grade and clinical grade supply, and the formats Honey X makes available to this buyer segment.
What "Medical Grade" Means in the Context of Honey Supply
The term "medical grade" in honey supply refers to a defined set of supply chain requirements, not a single property of the honey itself. It is the combination of independently verified antimicrobial activity at high Total Activity grades, batch-specific testing documentation, full traceability back to origin, and production under accredited quality systems.
Each of those requirements must be met simultaneously. A honey with high TA grading that lacks batch-specific documentation is not clinical-grade supply. A well-documented product from an accredited facility that has not been independently tested at the required TA threshold is equally unsuitable. Clinical supply buyers require all four elements to be present and verifiable.
Honey X supplies honey that meets all of these requirements. The supply is independently tested and third-party verified at Analytica (ALS) in New Zealand and ChemCentre in Western Australia, the laboratories most directly relevant to this verification standard.
The TA Grading Scale and What Clinical Buyers Look For
Total Activity (TA) is the primary metric for grading active WA honey. TA combines two distinct independently verified antimicrobial mechanisms: Peroxide Activity (PA), which is hydrogen peroxide-driven, and Non-Peroxide Activity (NPA), which is stable and not hydrogen-peroxide dependent.
The scale runs from TA10+ at moderate activity through TA20+, TA30+, TA40+, and TA50+ at elite grade. Honey X has achieved TA55+ as the highest grade verified in its supply.
Clinical supply chain buyers typically work with honey at TA30+ and above. At TA30+, the independently verified antimicrobial activity reaches the threshold considered meaningful for clinical supply purposes. Higher grades, TA40+ and TA50+, carry correspondingly higher documented activity levels. The buyer's own clinical protocols will determine the minimum TA threshold required for their specific application.
WDPE Testing: The Verification Method
The test method used to verify TA is the Well-Diffusion Phenol Equivalent (WDPE) assay. This is the accepted gold standard for measuring antimicrobial activity in honey, and it is the method used by Analytica (ALS) and ChemCentre, the labs Honey X uses for independent verification.
The WDPE method works as follows. Diluted honey is placed into a well in a petri dish with agar infused with Staphylococcus aureus bacteria. Over 24 hours, the antimicrobial compounds in the honey diffuse outward, inhibiting bacterial growth. The diameter of the bacteria-free zone is measured and compared against a phenol standard. The result is expressed as a TA grade: a TA30 result means the honey demonstrated the same antimicrobial activity as a 30% phenol solution under test conditions.
This is a quantified, reproducible, comparable result. It is not a subjective grading. All TA grades assigned to Honey X products are based on WDPE results from third-party independent testing. Honey X has conducted 153+ third-party tests across five laboratories, including Analytica (ALS), ChemCentre, and the University of Sydney. Batch-specific test certificates are available to approved buyers. Read more about how active WA honey is tested in the bioactivity testing overview.
Food Grade Versus Clinical Grade: The Supply Chain Distinction
Food grade honey meets food safety standards: HACCP compliance, absence of contaminants, correct moisture content, and standard traceability. That is the baseline for any reputable honey supply.
Clinical grade supply begins where food grade supply ends. The distinctions are in testing rigour, documentation depth, and batch traceability:
- Testing rigour: Clinical supply requires batch-specific WDPE results at defined TA thresholds. Food grade supply does not require antimicrobial activity testing.
- Documentation: Clinical supply buyers require certificates of analysis at the batch level, not the variety level. Each unit supplied must carry its own verified test result.
- Traceability: Clinical supply requires full traceability from hive location and harvest date through to the specific batch shipped. General food grade supply does not carry this level of traceability as a standard requirement.
- Production accreditation: Clinical supply is sourced from facilities operating under HACCP and BQUAL certification at minimum, with relevant offshore accreditations applicable to the destination market.
Honey X operates across all of these requirements for the buyer segments that need them. The documentation infrastructure exists. The accreditations are current. The testing is conducted per batch.
WA Jarrah Honey and Non-Peroxide Activity
WA Jarrah honey (Eucalyptus marginata) is particularly relevant to clinical supply because of its Non-Peroxide Activity (NPA) profile.
NPA is the stable component of honey's independently verified antimicrobial activity. Unlike Peroxide Activity, NPA is not dependent on hydrogen peroxide. The stability profile of NPA means it is maintained across storage conditions that would diminish peroxide-based activity over time.
This long-term stability is the reason NPA is the component of most direct relevance to clinical applications where shelf life and product integrity across the supply chain are procurement requirements. Manuka honey is well known for its NPA, linked to Methylglyoxal (MGO). WA Jarrah honey also carries meaningful NPA alongside PA, verified through the same WDPE methodology. For buyers already sourcing Manuka, WA Jarrah honey offers a complementary supply option with a distinct but equally rigorous bioactivity profile, as verified at Analytica (ALS).
Jarrah is available in grades from TA15 through TA55+. View the full active WA honey product range.
Supply Formats for Clinical Buyers
Honey X makes bulk honey supply available to clinical buyers in formats suited to clinical procurement volumes and downstream packaging requirements.
Bulk formats include 300kg drums and 1,400kg IBCs for high-volume clinical procurement, as well as 28kg pails and 14kg cubes for mid-volume or trial orders. Each format is available with batch-specific documentation and can be supplied under the certification basis required by the buyer's destination market.
For buyers who require honey in smaller or consumer-accessible formats, Honey X produces sachets across a full size range: 8g, 10g, 13g, 20g, 25g, and 30g. Jar and PET formats are also available. All formats are produced under HACCP-accredited production lines with full traceability back to batch.
Certification Basis
Honey X holds HACCP and BQUAL certification as the foundation of its quality system. BQUAL is the Australian honey industry's benchmark quality assurance programme and is the standard most relevant to clinical supply buyers in international markets who require an audited quality framework specific to honey production and handling.
Beyond these core certifications, Honey X holds 12+ certifications in total, including offshore accreditations for specific destination markets. Honey X is a registered importer for China, the UK, the USA, and Saudi Arabia, and the export documentation framework is designed to meet the requirements of clinical and regulatory buyers in each of these jurisdictions.
Certification documentation is available to approved buyers. View the Honey X contact page to enquire about certification specifics relevant to your market.
Heritage and Scientific Oversight
The Fewster family has been beekeeping in Western Australia since 1916, now in its fifth generation. The scientific oversight at Honey X is led by Mike Fewster, Chief Scientific Officer, who holds Bachelor's and Master's degrees in Applied Science and whose work underpins the Jarrah Factor™ grading system and all in-house screening protocols.
The combination of generational supply continuity and in-house scientific rigour is a meaningful distinction for clinical supply buyers who require confidence in both the consistency of supply and the accuracy of the documentation that accompanies it.
Over 200 tonnes of active WA honey have been tested across five independent laboratories. In-house screening is validated by those same independent laboratories. Every batch independently tested for activity, composition, and compliance before release.
Enquire About Clinical Supply Grading and Batch Documentation
If you are sourcing honey for a clinical supply chain and need to understand the TA grading available, the documentation standard, or the certification basis applicable to your market, the starting point is a direct conversation.
Honey X supplies buyers in 17+ markets from bulk drums and IBCs through to smaller packed formats. The testing, documentation, and traceability infrastructure is in place. The question is whether the specific grade, format, and certification basis you require is available for your destination market and volume.
View the active WA honey range, or enquire directly about clinical supply grading and batch documentation via the Honey X contact page.



